London · Delayed Price · Currency is GBP · Price in GBX Halma Earnings Call Transcripts
Fiscal Year 2026
-
Record half-year results driven by 15% revenue and 27% EBIT growth, with strong organic performance across all sectors and premium Photonics growth. Margin and returns improved, major investments made, and full-year guidance upgraded to mid-teens revenue growth and 22% EBIT margin.
Fiscal Year 2025
-
Record revenue and profit growth driven by strong organic performance, margin expansion, and exceptional photonics results. Robust cash generation enabled significant investment and a 7% dividend increase, with FY2026 guidance for upper single-digit organic growth and continued margin strength.
-
M&A is central to the growth strategy, targeting small to medium-sized, high-quality companies in attractive niches, with a decentralized, light-touch integration model. Incentives align across the group, focusing on sustainable, accretive returns, and regular portfolio reviews ensure ongoing strategic fit.
-
Record half-year revenue and profit driven by double-digit organic growth, strong margins, and robust cash generation. Safety and E&A sectors excelled, while Healthcare faced headwinds. Confident outlook for FY 2025 with continued investment in R&D and M&A.
Fiscal Year 2024
-
Record revenue and profit growth were achieved, driven by strong performance in Safety and E&A, robust cash generation, and disciplined M&A. Outlook for FY 2025 is positive, with continued investment and a 21% EBIT margin expected.